Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stabilization on, or Change-Over to the Non-Ergot Dopamine Agonist Piribedil in Patients With Morbus Parkinson - a Post Marketing Surveillance Study in Private Practices.

NCT00727727 is registered in ClinicalTrials.gov with Desitin Arzneimittel GmbH as lead sponsor.

NCT NCT00727727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00727727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stabilization on, or Change-Over to the Non-Ergot Dopamine Agonist Piribedil in Patients With Morbus Parkinson - a Post Marketing Surveillance Study in Private Practices.
Lead sponsor
Desitin Arzneimittel GmbH
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2008
Enrollment
750 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease